Document is current
Any future updates will be listed below
-
Authors
van Elst, Tessa
Mehra, Niven
Bloem, Sjaak
Vis, André N.
Wijsman, Bart P.
Luijendijk-de Bruin, Daphne
van Dodewaard-de Jong, Joyce M.
van den Berg, Pieter L.
Lavalaye, Jules
Aluwini, Shafak
Yakar, Derya
Oprea-Lager, Daniela E.
Mulders, Peter F. A.
Bloemendal, Haiko J.
van Basten, Jean-Paul A.
- License Information
-
More Information
Article History
Received: 17 June 2024
Accepted: 25 March 2025
First Online: 11 April 2025
Declarations
:
: TE reports funding for research from Johnson & Johnson. NM reports grants, institutional and personal fees from Johnson & Johnson. Outside of the submitted work, NM reports grants and personal fees from MSD, AstraZeneca, Astellas, BMS, Pfizer and Bayer. DY reports Astellas consultancy fee. Other authors did not report any relevant conflicts of interests.
: In accordance with Dutch legislation, studies of this nature are exempt from the review of a research ethics committee as the participants (i.e., the physicians) were not subjected to procedures or required to follow rules of behaviour. Therefore, this study was not submitted to an ethics committee/ institutional review board for approval. After providing the physicians with adequate information, we considered their consent to complete the survey and participate in the focus groups as sufficient informed consent for the study. The physicians participating in the focus groups explicitly consented to the videotaping of the focus group proceedings.
: All participants consented for publication.
